<x:xmpmeta xmlns:x="adobe:ns:meta/">
<rdf:RDF 
  xmlns:orkg="http://orkg.org/core#"
  xmlns:orkg_property="http://orkg.org/property"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#">
  <rdf:Description rdf:about="R1234565">
    <rdf:type rdf:resource="http://orkg.org/core#Paper"/>
    <orkg:hasResearchContribution>
      <orkg:ResearchContribution rdf:about="contribution_ORKG_default">
          <orkg_property:ORKGbackground>The role of antibiotic therapy in managing acute bacterial sinusitis (ABS) in children is controversial</orkg_property:ORKGbackground>
          <orkg_property:ORKGresearchproblem>effectiveness of high-dose amoxicillin/potassium clavulanate in the treatment of children diagnosed with ABS</orkg_property:ORKGresearchproblem>
          <orkg_property:ORKGmethod>randomized, double-blind, placebo-controlled study</orkg_property:ORKGmethod>
          <orkg_property:ORKGmethod>Patients were stratified according to age (&lt;6 or â‰¥6 years) and clinical severity and randomly assigned to receive either amoxicillin (90 mg/kg) with potassium clavulanate (6.4 mg/kg) or placebo</orkg_property:ORKGmethod>
          <orkg_property:ORKGresult>Children receiving the antibiotic were more likely to be cured (50vs 14and less likely to have treatment failure (14vs 68than children receiving the placebo</orkg_property:ORKGresult>
          <orkg_property:ORKGconclusion>Amoxicillin/potassium clavulanate results in significantly more cures and fewer failures than placebo</orkg_property:ORKGconclusion>
      </orkg:ResearchContribution>
    </orkg:hasResearchContribution>
  </rdf:Description>
</rdf:RDF>
</x:xmpmeta>